Skip to content

Effects of transcutaneous electrical acupoint stimulation on recovery quality of patients after Pterygium excision

Effects of transcutaneous electrical acupoint stimulation on recovery quality of patients after Pterygium excision

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005572
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-02-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pterygium

Interventions

control group:Pseudo-transcutaneous electrical acupoint stimulation

Sponsors

the First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients who have a clear diagnosis and require unilateral pterygium excision. (2) Aged 18 to 85 years. (3) Those with normal comprehension and communication skills. (4) Those who voluntarily join and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Localized skin infections. (2) Severe cardiovascular disease, severe lung, liver and kidney disease, etc. (3) Surgery lasting more than 3 hours. (4) Persons with mental illness or language communication and comprehension problems. (5) Long-term use of sedative and analgesic drugs. (6) Patients who have participated in other clinical trials within the last four weeks.

Design outcomes

Primary

MeasureTime frame
Postoperative quality of recovery score, QoR-40;

Secondary

MeasureTime frame
Numerical rating scale,NRS;State-trait anxiety inventory, STAI;Ramsay Sadation Scale,RSS;

Countries

China

Contacts

Public ContactYunchang Mo

the First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang Street, Ouhai District, Wenzhou, Zhejiang province, China

myc1104@wmu.edu.cn13736924260

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026